NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 25 Sept · 14:55 IST

Neuland Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has informed the stock exchanges that the trading window for dealing in its shares will be closed from October 1, 2025, until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2025. This closure is in line with the company's Insider Trading Code under SEBI regulations. The exact date of the board meeting to approve these Q2 and H1 FY26 results has not yet been announced and will be communicated later. During this period, insiders and designated persons are barred from trading in the company's shares.

Likely market impact

This is a routine regulatory disclosure and not material to the stock price. Investors should expect the company to announce its Q2 and H1 FY26 results in the coming weeks, which could be a key catalyst for the stock.